Dog /

Breed profile · FDA CVM July 2026 extract

Akita adverse-event record

Adverse-event filings for Akita (Dog) in the FDA Center for Veterinary Medicine openFDA extract. Browse dog breeds, reactions, and outcomes below.

Verify with FDA CVM →
#108 of 510
by report volume (all breeds)
1,118
FDA CVM reports on file
5.2%
death-coded share of reports
#121 of 275
by death-coded share (≥50 reports)

How the 1,118 reports break down

By recorded gender -- every report on file for Akita, no filtering.

Annual report volume

Annual adverse-event report trend Yearly FDA CVM adverse-event report counts for this breed. 75 56.25 37.5 18.75 0 2019 2020 2021 2022 2023 2024 2025 2026 Reports filed Death-coded reports
Annual report volume for Akita drawn from FDA CVM filings.

Data updated September 2026

The verdict

According to the FDA Center for Veterinary Medicine openFDA adverse-event extract, Akita ranks #108 of 510 by total reports (1,118) and #121 of 275 by death-coded share (5.2%). National dual: Retriever - Labrador is #1 of 510 by total adverse-event reports (93,675) at death-coded-share rank 195 of 275 breeds with at least 50 reports (3.7%); separately, Atlantic Salmon (Salmo salar) is #1 highest death-coded share at 99.0% (report rank #233).

93,675
Retriever - Labrador reports (#1)
99.0%
Atlantic Salmon (Salmo salar) death share (#1)
#108
This breed, reports of 510
#121
This breed, death share of 275

Report volume reflects how common a breed or drug is and how often owners and vets file — not actual risk. Death-coded share ranks are limited to entries with enough reports to be meaningful. The two maps do not agree at #1.

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Akita has 1,118 reports now versus 1,108 in that prior snapshot: 10 more (0.9%).

Report change
+10
Death-coded reports
+0
Death-coded share
−0.0 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Akita changes

Total Reports

1,118

High report volume

Deaths Reported

58

of 1,118 reports

Death-coded share of reports

5.2%

Above-median death-coded share

Avg Age at Report

5.5 yr

37.5 kg avg weight

Breed Safety Scorecard

D (44/100)

A weighted composite across 4 of 4 dimensions, each benchmarked against every tracked breed with at least 200 reports (n=185). Dimensions with insufficient data drop out and their weight redistributes to the rest, so a missing input never silently deflates the score.

Death rate D
5.2%

Share of reports coded as a fatality

Euthanasia rate D
2.1%

Share of reports resulting in euthanasia

Full recovery rate C
30.1%

Share of reports coded "Recovered/Normal"

5-year trend F
+33%

Change in annual report volume over the last 5 complete years

Death-Coded Outcome Share

Akita death-coded reports 5.2%
Cross-breed median

5.2% of 1,118 akita reports involved a death outcome.

How to read this number

Read alongside breed popularity, veterinary access, and owner awareness, these shape how many events ever reach the FDA. The comparison line marks the cross-breed median death-coded share (4.8%) among breeds with 50 or more reports; values above it suggest higher reporting bias toward severe outcomes, not necessarily higher true mortality.

Where Akita's death-coded share sits among indexed breeds

Death-coded share of FDA CVM reports, breeds with ≥50 reports (July 2026 extract)

5% 56th percentile Higher share than 56% of 275 indexed breeds

5%–10%: 1 indexed breeds (0%). This entry sits in this band. 20%–25%: 2 indexed breeds (1%). Above this entry. 25%–30%: 3 indexed breeds (1%). Above this entry. 30%–35%: 4 indexed breeds (1%). Above this entry. 35%–40%: 5 indexed breeds (2%). Above this entry. 40%–45%: 6 indexed breeds (2%). Above this entry. 45%–50%: 3 indexed breeds (1%). Above this entry. 50%–55%: 7 indexed breeds (3%). Above this entry. 55%–60%: 7 indexed breeds (3%). Above this entry. 60%–65%: 21 indexed breeds (8%). Above this entry. 65%–70%: 11 indexed breeds (4%). Above this entry. 70%–75%: 15 indexed breeds (5%). Above this entry. 75%–80%: 13 indexed breeds (5%). Above this entry. 80%–85%: 11 indexed breeds (4%). Above this entry. 85%–90%: 12 indexed breeds (4%). Above this entry. 90%–95%: 12 indexed breeds (4%). Above this entry. 95%–100%: 142 indexed breeds (52%). Above this entry. Akita 5% 100% every breed with ≥50 FDA reports, bucketed by value

Each bar is a band; taller bars hold more indexed breeds. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source FDA Center for Veterinary Medicine, openFDA adverse event extract (PlainBreed) · July 2026 extract

This histogram uses the same ≥50-report cohort as the highest death-coded share ranking. A higher share means more of this breed's reported events were death-coded, not a mortality rate for living animals.

Average weight at time of report: 37.5 kg (82.7 lbs)

Top Reported Reactions

Vomiting 179
Lethargy (see also Central nervous system depression in 'Neurological') 126
Emesis 92
Diarrhoea 80
INEFFECTIVE, HEARTWORM LARVAE 77
Lack of efficacy (endoparasite) - heartworm 66
Lack of efficacy - NOS 49
Seizure NOS 48
Lack of efficacy (ectoparasite) - flea 47
Behavioural disorder NOS 44
Other abnormal test result NOS 43
Anorexia 41
Lack of efficacy (bacteria) - Borrelia 33
Ataxia 32
Panting 29

Most Referenced Drugs

Milbemycin Oxime + Spinosad 217
Ivermectin + Pyrantel As Pamoate Salt 98
Afoxolaner 83
Spinosad 79
Pyrantel Pamoate;Sarolaner 68
Carprofen 49
Bedinvetmab 48
Fluralaner Chew Tablets 44
Oclacitinib Maleate 43
Moxidectin 35
Milbemycin Oxime + Praziquantel 33
Fluralaner 13.64% 12-Week Chew 29
Selamectin 25
Prednisone 21
Grapiprant 20

Outcome Breakdown

Recovered/Normal
337 (32.1%)
Outcome Unknown
325 (31.0%)
Ongoing
278 (26.5%)
Recovered with Sequela
52 (5.0%)
Died
34 (3.2%)
Euthanized
24 (2.3%)

Gender Distribution

Male 581 (52.0%)
Female 512 (45.8%)
Unknown 18 (1.6%)
Mixed 7 (0.6%)

Reports by Year

Year Reports Trend
2010 34
2011 65
2012 90
2013 77
2014 92
2015 94
2016 85
2017 75
2018 74
2019 59
2020 49
2021 52
2022 62
2023 59
2024 75
2025 69
2026 7

Akita: high-volume FDA adverse-event cohort

Signature read: 1,118 reports place Akita in the upper third of breed filing volume (#108 of 510). According to FDA CVM filings indexed on PlainBreed as of July 2026 extract, Akita sits at #108 of 510 by report volume among all breeds and #90 of 298 among dog breeds, with 1,118 reports and 58 (5.2%) death-coded. On death-coded share among breeds with ≥50 reports, it ranks #121 of 275. Mean age at report: 5.5 years, average weight 37.5 kg (82.7 lbs).

Top reported signs: Vomiting (179), Lethargy (see also Central nervous system depression in 'Neurological') (126), Emesis (92). Most-referenced drug: Milbemycin Oxime + Spinosad (217 reports), followed by Ivermectin + Pyrantel As Pamoate Salt (98) and Afoxolaner (83).

Outcome coding on 1,050 status-recorded reports is dominated by Recovered/Normal (32.1%). Annual submissions ranged 7-2,026 across 17 years on file.

Dog Breeds With a Similar Report Volume

Showing 6 of 297 dog breeds in our dataset, ranked by closest report volume.

Dachshund - Standard Long-haired
1,136 reports · 6.1% death-coded
Bulldog - English
1,142 reports · 9.1% death-coded
Spitz - American Eskimo Dog
1,149 reports · 4.6% death-coded
Retriever - Chesapeake Bay
1,073 reports · 3.0% death-coded
Bloodhound
1,043 reports · 3.5% death-coded
Terrier - Bull
1,033 reports · 4.5% death-coded

Nationwide breeds with similar profiles

High-volume peer sets for Akita drawn from openFDA outside the Dog family so the neighborhoods are not species containment (the similar-volume list above stays within species).

Similar death-coded share

Nearest other-species breeds with ≥50 reports (5.2% death-coded here).

Egyptian Mau 5.3% · Cat Scottish Fold Longhair 4.8% · Cat Norwegian Forest 5.7% · Cat Bengal 4.6% · Cat

What to do with this dog

A report does not prove a drug caused the reaction, and popular breeds simply generate more reports.

Frequently Asked Questions

How many FDA adverse event reports involve Akita? ▼
There are 1,118 adverse event reports involving Akita in the FDA database, of which 58 were death-coded (5.2% of those reports). That is a share of REPORTED events, not a mortality rate for the breed: adverse events reach the FDA when something goes wrong, so the denominator is reports, never the population of animals. According to the same FDA CVM extract, Akita ranks #108 of 510 by report volume among all breeds PlainBreed indexes (#90 of 298 among dog breeds).
Where does Akita sit among other breeds in PlainBreed's corpus? ▼
According to FDA CVM report volume, Akita is #108 of 510 breeds indexed on PlainBreed (same ordering as the most-reported-breeds ranking). Inside Dog, it is #90 of 298. Among breeds with at least 50 reports, its death-coded share ranks #121 of 275 (same cohort as highest-death-rate). These are placement ranks in the reporting corpus, not clinical risk scores.
What are the most common adverse reactions reported for Akita? ▼
The most commonly reported adverse reactions for Akita are Vomiting (179 reports), Lethargy (see also Central nervous system depression in 'Neurological') (126 reports), Emesis (92 reports), Diarrhoea (80 reports), INEFFECTIVE, HEARTWORM LARVAE (77 reports).
What drugs are most frequently associated with Akita adverse events? ▼
The drugs most frequently referenced in Akita adverse event reports are Milbemycin Oxime + Spinosad (217 reports), Ivermectin + Pyrantel As Pamoate Salt (98 reports), Afoxolaner (83 reports), Spinosad (79 reports), Pyrantel Pamoate;Sarolaner (68 reports).
What is the average age of Akita in adverse event reports? ▼
The average age of Akita at the time of adverse event reports is 5.5 years, with an average weight of 37.5 kg (82.7 lbs).

Compare a breed's report volume against how common the breed is before drawing conclusions. See our methodology for how the death-coded share and rankings are computed, or read breed-specific reporting patterns and FDA CVM reporting.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Akita (Dog), extract as of July 2026 extract. 1,118 reports · 58 death-coded (5.2% of reports, not a mortality rate) · #108 of 510 by volume.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →